Evidence mapPaperPMID 37416849Full record

ReviewJournal of healthcare leadership2023

Bridging the "Know-Do" Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science.

James F Donohue, J Stuart Elborn, Peter Lansberg, Afzal Javed, Solomon Tesfaye, Hope Rugo, Sita Ratna Devi Duddi, Niraksha Jithoo, Pai-Hui Huang, Kannan Subramaniam and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of healthcare leadership, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
20.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. So what? Elevating the impact of implementation science.Implementation science communications · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Chronic kidney disease.Nature reviews. Disease primers · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 7 countries.

James F DonohueUNC School of Medicine, Chapel Hill, NC, USA.ORCID 0000-0002-4439-6866
J Stuart ElbornQueen's University, Belfast, UK.
Peter LansbergUniversity Medical Center, Groningen, the Netherlands.ORCID 0000-0003-2539-239X
Afzal JavedWarwick Medical School, University of Warwick, Warwick, UK & Pakistan Psychiatric Research Centre, Coventry, UK.
Solomon TesfayeSheffield Teaching Hospitals and the University of Sheffield, Sheffield, UK.
Hope RugoUniversity of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA.
Sita Ratna Devi DuddiInternational Alliance of Patients' Organisations, London, United Kingdom.ORCID 0000-0002-9817-3836
Niraksha JithooViatris Ltd, Johannesburg, South Africa.
Pai-Hui HuangViatris Pharmaceutical Co., Ltd, Taipei, Taiwan.
Kannan SubramaniamViatris Ltd, Auckland, New Zealand.ORCID 0000-0001-5551-4103
Nagendra RamanjinappaViatris Ltd, Bangalore, India.
Arkady KoltunViatris Ltd, Canonsburg, PA, USA.
Shari MelamedViatris Ltd, Canonsburg, PA, USA.
Juliana C N ChanDepartment of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Special Administrative Regions of the People's Republic of China.ORCID 0000-0003-1325-1194
Tris Pharma (United States) · USAuckland Institute of Studies · NZCentre for Development Economics · INChinese University of Hong Kong · HKQueen's University Belfast · GBSheffield Teaching Hospitals NHS Foundation Trust · GBUniversity Medical Center Groningen · NLUniversity of California, San Francisco · USUniversity of North Carolina Health Care · USUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to the United Nations High-Level Meeting 2018, five non-communicable diseases (NCDs) including cardiovascular diseases, chronic respiratory diseases, diabetes mellitus, cancer, and mental health conditions accounted for two-thirds of global deaths. These five NCDs share five common risk factors including tobacco use, unhealthy diets, physical inactivity, alcohol use, and air pollution. Low- and middle-income countries (LMICs) face larger burden of NCDs than high-income countries (HICs), due to differences in ecological, technological, socioeconomic and health system development. Based on high-level evidence albeit mainly from HICs, the burden caused by NCDs can be reduced by affordable medicines and best practices. However, "know-do" gaps, ie, gaps between what we know in science and what we do in practice, has limited the impact of these strategies, especially in LMICs. Implementation science advocates the use of robust methodologies to evaluate sustainable solutions in health, education and social care aimed at informing practice and policies. In this article, physician researchers with expertise in NCDs reviewed the common challenges shared by these five NCDs with different clinical courses. They explained the principles of implementation science and advocated the use of an evidence-based framework to implement solutions focusing on early detection, prevention and empowerment, supplemented by best practices in HICs and LMICs. These successful stories can be used to motivate policymakers, payors, providers, patients and public to co-design frameworks and implement context-relevant, multi-component, evidence-based practices. In pursuit of this goal, we propose partnership, leadership, and access to continuing care as the three pillars in developing roadmaps for addressing the multiple needs during the journey of a person with or at risk of these five NCDs. By transforming the ecosystem, raising awareness and aligning context-relevant practices and policies with ongoing evaluation, it is possible to make healthcare accessible, affordable and sustainable to reduce the burden of these five NCDs.

Indexed as

evidence-based practiceshealthcare policiesimplementation scienceknow-do gapsnon-communicable diseases

Identifiers

PMID37416849
PMCPMC10320809
OpenAlexW4382940427

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.